Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Clinical Outcome
16 results:

  • 1. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
    Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
    Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. STR Profiling Reveals Tumor Genome Instability in Primary Mediastinal B-Cell Lymphoma.
    Risinskaya N; Mangasarova Y; Nikulina E; Kozhevnikova Y; Chabaeva J; Yushkova A; Magomedova A; Kulikov S; Julhakyan H; Kravchenko S; Sudarikov A
    Curr Oncol; 2022 May; 29(5):3449-3459. PubMed ID: 35621668
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Laminin 521 enhances self-renewal via STAT3 activation and promotes tumor progression in colorectal cancer.
    Qin Y; Shembrey C; Smith J; Paquet-Fifield S; Behrenbruch C; Beyit LM; Thomson BNJ; Heriot AG; Cao Y; Hollande F
    Cancer Lett; 2020 Apr; 476():161-169. PubMed ID: 32105676
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CXCL-13 Regulates Resistance to 5-Fluorouracil in colorectal cancer.
    Zhang G; Luo X; Zhang W; Chen E; Xu J; Wang F; Cao G; Ju Z; Jin D; Huang X; Zhou W; Song Z
    Cancer Res Treat; 2020 Apr; 52(2):622-633. PubMed ID: 32019285
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. High Frequency of KRAS Codon 146 and FBXW7 Mutations in Thai Patients with Stage II-III Colon cancer.
    Korphaisarn K; Pongpaibul A; Roothumnong E; Pongsuktavorn K; Thamlikitkul L; Anekpuritanang T; Poungvarin N; Thongnoppakhun W; Pithukpakorn M
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2319-2326. PubMed ID: 31450901
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient Registry.
    Stuart E; Banerjee S; de la Torre J; Wang Y; Scherzer N; Burgoyne AM; Parry L; Fanta PT; Ramamoorthy S; Sicklick JK
    J Surg Oncol; 2019 Sep; 120(4):715-721. PubMed ID: 31297829
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I colorectal cancer.
    Reggiani Bonetti L; Barresi V; Maiorana A; Manfredini S; Caprera C; Bettelli S
    Dis Markers; 2018; 2018():2959801. PubMed ID: 30018674
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular correlates and prognostic value of tmTNF-α expression in colorectal cancer of 5-Fluorouracil-Based Adjuvant Therapy.
    Li X; Wang S; Ren H; Ma J; Sun X; Li N; Liu C; Huang K; Xu M; Ming L
    Cancer Biol Ther; 2016 Jun; 17(6):684-92. PubMed ID: 27224726
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm.
    Kearns B; Whyte S; Seaman HE; Snowball J; Halloran SP; Butler P; Patnick J; Nickerson C; Chilcott J
    Br J Cancer; 2016 Feb; 114(3):327-33. PubMed ID: 26766733
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
    Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL
    Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The usability of allele-specific PCR and reverse-hybridization assays for KRAS genotyping in Serbian colorectal cancer patients.
    Brotto K; Malisic E; Cavic M; Krivokuca A; Jankovic R
    Dig Dis Sci; 2013 Apr; 58(4):998-1003. PubMed ID: 23108567
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel cancer Screening Programme.
    Lee TJ; Clifford GM; Rajasekhar P; Rutter MD; Kometa S; Ritchie MC; Waddup G; Nylander D; McNally RJ; Rees CJ
    J Med Screen; 2011; 18(2):82-6. PubMed ID: 21852700
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer.
    Garm Spindler KL; Pallisgaard N; Rasmussen AA; Lindebjerg J; Andersen RF; Crüger D; Jakobsen A
    Ann Oncol; 2009 May; 20(5):879-84. PubMed ID: 19179548
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. kit/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
    Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
    Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery.
    Galizia G; Lieto E; Ferraraccio F; De Vita F; Castellano P; Orditura M; Imperatore V; La Mura A; La Manna G; Pinto M; Catalano G; Pignatelli C; Ciardiello F
    Ann Surg Oncol; 2006 Jun; 13(6):823-35. PubMed ID: 16614884
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. COX-2, c-kit and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?
    Raspollini MR; Susini T; Amunni G; Paglierani M; Taddei A; Marchionni M; Scarselli G; Taddei GL
    Gynecol Oncol; 2005 Jan; 96(1):159-67. PubMed ID: 15589595
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.